Success Stories

Event Videos

Quantitative assessment of liver steatosis on tissue section using infrared spectroscopy http://www.ncbi.nlm.nih.gov/pubmed/25461852 Le Naour F, Gadea L, Danulot M, Yousef I, Vibert E, Wavelet M, Kaščáková S, Castaing D, Samuel D, Dumas P, Guettier C. Quantitative assessment of liver steatosis on tissue section using infrared spectroscopy. Gastroenterology. 2015 Feb; 148(2): 295-7. Published on: Feb-2015	Chronic hepatitis B virus infection in children and adolescents in Japan http://www.ncbi.nlm.nih.gov/pubmed/25221937 Komatsu H, Inui A, Sogo T, Tsunoda T, Fujisawa T. Chronic hepatitis B virus infection in children and adolescents in Japan. J Pediatr Gastroenterol Nutr. 2015 Jan; 60(1): 99-104. Abstract BACKGROUND: Hepatitis B e antigen (HBeAg) seroconversion is an important event in patients with chronic hepatitis B virus (HBV) infection. This study aimed to clarify the outcome of long-term follow-up of chronic HBV infection and the factors affecting HBeAg seroconversion in children in Japan. METHODS: Published on: Jan-2015 Read more
Circulating MicroRNAs as Noninvasive Diagnostic Biomarkers of Liver Disease in Children With Cystic Fibrosis http://www.ncbi.nlm.nih.gov/pubmed/25625579 Cook NL, Pereira TN, Lewindon PJ, Shepherd RW, Ramm GA. Circulating MicroRNAs as Noninvasive Diagnostic Biomarkers of Liver Disease in Children With Cystic Fibrosis. J Pediatr Gastroenterol Nutr. 2015 Feb; 60(2): 247-54. Abstract OBJECTIVES: Published on: Feb-2015 Read more	Cost-effective analysis of screening for biliary atresia with the stool color card http://www.ncbi.nlm.nih.gov/pubmed/25221934 Mogul D, Zhou M, Intihar P, Schwarz K, Frick K. Cost-effective analysis of screening for biliary atresia with the stool color card. J Pediatr Gastroenterol Nutr. 2015 Jan; 60(1):91-8. Abstract BACKGROUND: Biliary atresia (BA) is the leading cause of pediatric end-stage liver disease and liver transplantation in the United States. Early diagnosis leads to improved outcomes, but diagnosis is often delayed, leading to increased rates of transplantation and mortality. METHODS: Published on: Jan-2015 Read more
Investigation of cardiomyopathy in children with cirrhotic and noncirrhotic portal hypertension. http://www.ncbi.nlm.nih.gov/pubmed/25250684 Celtik C, Durmaz O, Oner N, Yavuz T, Gökce S, Aydogan A, Nisli K, Emiroglu HH, Ömeroglu RE, Sökücü S. Investigation of cardiomyopathy in children with cirrhotic and noncirrhotic portal hypertension. J Pediatr Gastroenterol Nutr. 2015 Feb; 60(2): 177-81. Abstract BACKGROUND: Cirrhotic cardiomyopathy (CCMP) is a functional disorder characterized by electrophysiological disturbances, and diastolic and/or systolic dysfunction in patients with liver disease. This disorder is a well-defined entity in adults, but pediatric data are limited. The aim of the study was to determine the incidence, features, and risk factors of CCMP in children with portal hypertension (PHT). METHODS: Published on: Feb-2015 Read more	Successful use of long-acting octreotide for intractable chronic gastrointestinal bleeding in children http://www.ncbi.nlm.nih.gov/pubmed/25162361 O'Meara M, Cicalese MP, Bordugo A, Ambrosi A, Hadzic N, Mieli-Vergani G. Successful use of long-acting octreotide for intractable chronic gastrointestinal bleeding in children. J Pediatr Gastroenterol Nutr. 2015 Jan; 60(1):48-53. Abstract BACKGROUND AND AIMS: Published on: Jan-2015 Read more
Fulminant hepatic failure of autoimmune aetiology in children http://www.ncbi.nlm.nih.gov/pubmed/25304891 Di Giorgio A, Bravi M, Bonanomi E, Alessio G, Sonzogni A, Zen Y, Colledan M, D'Antiga L. Fulminant hepatic failure of autoimmune aetiology in children. J Pediatr Gastroenterol Nutr. 2015 Feb; 60(2): 159-64. Abstract OBJECTIVE: Autoimmune hepatitis (AIH) is considered an underdiagnosed cause of fulminant hepatic failure (FHF). Autoimmune FHF (AI-FHF) is believed to lead invariably to liver transplantation (LTX) or death. We aimed to describe the autoimmune features of children diagnosed as having AI-FHF and indeterminate FHF (ID-FHF), and describe the outcome of patients with AI-FHF treated with immunosuppressive drugs. METHODS: Published on: Feb-2015 Read more	Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents http://www.ncbi.nlm.nih.gov/pubmed/24989077 Ayonrinde OT, Olynyk JK, Marsh JA, Beilin LJ, Mori TA, Oddy WH, Adams LA. Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents. J Gastroenterol Hepatol. 2015 Jan; 30(1):163-71. Abstract BACKGROUND AND AIM: Nonalcoholic fatty liver disease (NAFLD) and its metabolic risk factors are recognized during childhood and adolescence. Identification of adolescents at risk of NAFLD from childhood anthropometry may expose opportunities to influence the hepatic and metabolic destinies of individuals. We sought associations between NAFLD diagnosed during adolescence and earlier life trajectories of anthropometry, in a population-based cohort of predominantly Caucasian adolescents. METHODS: Published on: Jan-2015 Read more
Hepatic steatosis is prevalent in stillborns delivered to women with diabetes mellitus http://www.ncbi.nlm.nih.gov/pubmed/25079479 Patel KR, White FV, Deutsch GH. Hepatic steatosis is prevalent in stillborns delivered to women with diabetes mellitus. J Pediatr Gastroenterol Nutr. 2015 Feb;60(2): 152-8. Abstract OBJECTIVE: Maternal diabetes is a risk factor for pregnancy complications, including stillbirth and macrosomia. Evolving data suggest that diabetes during pregnancy also has long-term consequences for offspring, putting them at risk for obesity and the metabolic syndrome in childhood. Because nonalcoholic fatty liver disease is known to occur in adults and children with insulin resistance, we hypothesized that altered lipid metabolism in fetuses of diabetic mothers may manifest with hepatic steatosis. METHODS: Published on: Feb-2015 Read more	Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection http://www.ncbi.nlm.nih.gov/pubmed/24995497 Hann HW, Wan S, Lai Y, Hann RS, Myers RE, Patel F, Zhang K, Ye Z, Wang C, Yang H. Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol. 2015 Jan; 30(1):131-8. Abstract BACKGROUND AND AIM: APRI (aspartate aminotransferase [AST] to platelet ratio index) is widely used to assess fibrosis and cirrhosis risk, especially in hepatitis C virus (HCV)-infected patients. Few studies have evaluated APRI and hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) risk. Prospective evidence is needed to assess whether APRI predicts HCC risk in HBV patients. METHOD: Published on: Jan-2015 Read more

CLF Intro movie

SMS requests to

9224791366

Ask The Expert

Pediatric Liver Specialists in India

Centres offering Genetic Testing for Pediatric Liver Diseases

Financial Aid Offered by Trusts

Follow us on:

Facebook Twitter YouTube